Leveraging influenza virus surveillance from 2012 to 2015 to characterize the burden of respiratory syncytial virus disease in Canadian adults≥ 50 years of age …
M ElSherif, MK Andrew, L Ye, A Ambrose… - Open Forum …, 2023 - academic.oup.com
Background Respiratory syncytial virus (RSV) disease in older adults is undercharacterized.
To help inform future immunization policies, this study aimed to describe the disease burden …
To help inform future immunization policies, this study aimed to describe the disease burden …
Pneumococcal Vaccine Breakthrough and Failure in Infants and Children: A Narrative Review
K Feemster, J Weaver, U Buchwald, N Banniettis… - Vaccines, 2023 - mdpi.com
Globally, Streptococcus pneumoniae is a leading cause of vaccine-preventable morbidity
and mortality in infants and children. In recent decades, large-scale pediatric immunization …
and mortality in infants and children. In recent decades, large-scale pediatric immunization …
Streptococcus pneumoniae serotyping and antimicrobial susceptibility: assessment for vaccine efficacy in Canada after the introduction of PCV13
GG Zhanel, JP Lynch III, HJ Adam - Journal of Antimicrobial …, 2023 - academic.oup.com
Background Streptococcus pneumoniae continues to be an important bacterial pathogen
associated with invasive (eg bacteraemia, meningitis) and non-invasive (eg community …
associated with invasive (eg bacteraemia, meningitis) and non-invasive (eg community …
Estimating the risk of bacteraemia in hospitalised patients with pneumococcal pneumonia
L Serrano, LA Ruiz, S Pérez, PP España, A Gomez… - Journal of Infection, 2022 - Elsevier
Objective To construct a prediction model for bacteraemia in patients with pneumococcal
community-acquired pneumonia (P-CAP) based on variables easily obtained at hospital …
community-acquired pneumonia (P-CAP) based on variables easily obtained at hospital …
[HTML][HTML] Community-Acquired Pneumococcal Pneumonia in Highly Vaccinated Population: Analysis by Serotypes, Vaccination Status, and Underlying Medical …
H Hyun, AY Jang, JW Suh, IG Bae… - Journal of Korean …, 2023 - ncbi.nlm.nih.gov
Background Targeted risk population has been highly vaccinated against pneumococcal
diseases in South Korea. Despite this, the pneumococcal serotype distribution is evolving …
diseases in South Korea. Despite this, the pneumococcal serotype distribution is evolving …
[HTML][HTML] Clinical and economic burden of invasive pneumococcal disease and noninvasive all-cause pneumonia in hospitalized US adults: A multicenter analysis from …
S Mohanty, N Cossrow, CY Kalvin, G Ye… - International Journal of …, 2024 - Elsevier
Objectives To evaluate the clinical and economic outcomes in adults hospitalized with
invasive pneumococcal disease (IPD) and noninvasive all-cause pneumonia (ACP) overall …
invasive pneumococcal disease (IPD) and noninvasive all-cause pneumonia (ACP) overall …
Indirect impact of childhood 13-valent pneumococcal conjugate vaccine (PCV13) in Canadian older adults: a Canadian Immunization Research Network (CIRN) …
Background 13-valent pneumococcal conjugate vaccine (PCV13) has been part of publicly
funded childhood immunisation programmes in Ontario and British Columbia (BC) since …
funded childhood immunisation programmes in Ontario and British Columbia (BC) since …
[PDF][PDF] Une déclaration du comité consultatif (DCC) Comité consultatif national de l'immunisation (CCNI)
PLESCETL DONNER, DALS LES MOYENS - 2024 - canada.ca
Pour obtenir plus d'information, veuillez communiquer avec: Agence de la santé publique du
Canada Indice de l'adresse 0900C2 Ottawa (Ontario) K1A 0K9 Tél.: 613-957-2991 Sans …
Canada Indice de l'adresse 0900C2 Ottawa (Ontario) K1A 0K9 Tél.: 613-957-2991 Sans …